XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 14, 2023
Jun. 30, 2024
Successor [Member]      
Operating activities      
Net loss $ (11,972)   $ (10,426)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 28   44
Amortization of intangible assets 813   1,366
Amortization of right of use asset 102   201
Provision for credit loss expense 1  
Amortization of debt discount and deferred financing cost   445
Accrued interest expense on promissory note and convertible debt   210
Accrued monitoring fee on promissory note   408
Deferred income taxes (2,541)   (366)
Stock-based compensation expense 98   1,436
(Gain) loss on foreign currency transactions (4)   84
Change in fair value of derivative liability 10,354   2,523
Change in operating assets and liabilities:      
Accounts receivable and other receivables 962   1,555
Prepaid expenses and other current assets 152   (76)
Other assets (37)  
Accounts payable 281   (389)
Accrued liabilities (4,399)   574
Operating lease liabilities (102)   (212)
Other noncurrent liabilities  
Deferred revenue (334)   63
Net cash used in operating activities (6,598)   (2,560)
Investing activities      
Purchases of property and equipment (26)   (26)
Investment in capitalized software  
Cash acquired in connection with Business Combination 10,003  
Net cash provided by (used in) investing activities 9,977   (26)
Financing activities      
Proceeds from issuance of convertible debt, net of issuance costs   2,480
Net equity investment from parent  
Repayment of CXApp acquisition liability  
Repayment of related party promissory note (328)  
Net cash provided by (used in) financing activities (328)   2,480
Effect of exchange rate changes on cash and cash equivalents (11)   (9)
Net increase (decrease) in cash and cash equivalents 3,040   (115)
Cash and cash equivalents, beginning of period 1,503   6,275
Cash and cash equivalents, end of period 4,543   6,160
Supplemental disclosures of cash flow information      
Cash paid for taxes   25
Cash paid for interest 6  
Supplemental schedule of noncash investing and financing activities      
Right of use asset obtained in exchange for lease liability 230   393
Noncash investment from parent  
Class A Common Stock and Class C Common Stock issued in connection with Business Combination 69,928  
Financing of Director and Officer Insurance $ 671  
Predecessor [Member]      
Operating activities      
Net loss   $ (4,380)  
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization   228  
Amortization of intangible assets   806  
Amortization of right of use asset   40  
Amortization of debt discount and deferred financing cost    
Accrued interest expense on promissory note and convertible debt    
Accrued monitoring fee on promissory note    
Deferred income taxes    
Stock-based compensation expense   158  
(Gain) loss on foreign currency transactions   (32)  
Change in fair value of derivative liability    
Change in operating assets and liabilities:      
Accounts receivable and other receivables   (857)  
Prepaid expenses and other current assets   (20)  
Other assets    
Accounts payable   (796)  
Accrued liabilities   (787)  
Operating lease liabilities   (38)  
Other noncurrent liabilities    
Deferred revenue   534  
Net cash used in operating activities   (5,144)  
Investing activities      
Purchases of property and equipment   (9)  
Investment in capitalized software   (45)  
Cash acquired in connection with Business Combination    
Net cash provided by (used in) investing activities   (54)  
Financing activities      
Proceeds from issuance of convertible debt, net of issuance costs    
Net equity investment from parent   9,089  
Repayment of CXApp acquisition liability   (197)  
Repayment of related party promissory note    
Net cash provided by (used in) financing activities   8,892  
Effect of exchange rate changes on cash and cash equivalents   1  
Net increase (decrease) in cash and cash equivalents   3,695  
Cash and cash equivalents, beginning of period   6,308  
Cash and cash equivalents, end of period   10,003  
Supplemental disclosures of cash flow information      
Cash paid for taxes    
Cash paid for interest    
Supplemental schedule of noncash investing and financing activities      
Right of use asset obtained in exchange for lease liability    
Noncash investment from parent   409  
Class A Common Stock and Class C Common Stock issued in connection with Business Combination    
Financing of Director and Officer Insurance